ABVX
Abivax S.A.
105.00$
-1.8%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 14.9% | 56.6% | 45.9% | 38.8% | 38.8% | 35.3% | 52.8% | 68.9% | 47.9% | 87.4% | 83.2% | 94.3% | |
| 3.2% | 32.9% | 13.1% | 3.5% | 14.8% | 18.9% | 41.1% | 55.6% | 35.7% | 77.0% | 70.3% | 88.4% | |
| 7.7% | 51.3% | 37.9% | 31.6% | 24.1% | 18.9% | 41.1% | 55.6% | 35.7% | 79.8% | 70.3% | 90.8% | |
| 6.3% | 5.1% | 7.9% | 6.8% | 14.4% | 13.5% | 11.3% | 7.6% | 11.0% | 5.8% | 7.6% | 1.8% | |
| – | 0.2% | 0.1% | 0.4% | – | 2.2% | 1.6% | 3.7% | 16.1% | -1.8% | – | – | |
| – | – | – | – | – | 0.3% | 0.1% | 0.3% | 2.1% | – | – | – | |
| 84.3% | 42.0% | 52.8% | 59.5% | 59.2% | 61.9% | 44.9% | 30.0% | 24.4% | 5.6% | 9.0% | 3.2% | |
| 0.0% | 0.0% | – | – | – | 0.2% | 0.1% | -0.6% | 8.7% | 2.0% | 3.2% | 1.1% | |
| 10.6% | 5.9% | 6.4% | 10.5% | 35.9% | 64.1% | 74.9% | 76.3% | 90.5% | 40.1% | 80.2% | 22.1% | |
| 5.0% | 4.9% | 5.9% | 10.1% | 15.7% | 24.0% | 27.2% | 29.5% | 68.1% | 26.9% | 45.2% | 10.8% | |
| 0.0% | 0.4% | 0.4% | 0.3% | 20.2% | 40.1% | 0.0% | 9.4% | 39.8% | 9.6% | 21.3% | 5.0% | |
| 2.8% | 3.7% | 4.2% | 7.8% | 12.3% | 20.4% | 24.4% | 17.0% | 20.5% | 14.4% | 21.4% | 6.4% | |
| – | – | – | – | – | 40.1% | 39.9% | 48.9% | 48.4% | 13.7% | 25.4% | – | |
| 89.4% | 94.1% | 93.6% | 89.5% | 64.1% | 35.9% | 25.1% | 23.7% | 9.5% | 59.9% | 19.8% | 77.9% | |
| -13.4% | -27.6% | -58.3% | -86.5% | -115.4% | -179.8% | -52.7% | -74.9% | -190.0% | -86.5% | -213.8% | -126.4% | |
| 24.4% | 12.8% | 16.1% | 18.5% | 18.9% | 23.5% | 20.1% | 14.1% | 25.3% | 13.2% | 30.7% | 11.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.